Concise Review: Emerging Drugs Targeting Epithelial Cancer Stem-Like Cells
Open Access
- 1 March 2017
- journal article
- review article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 35 (4) , 839-850
Abstract
Increasing evidence suggests that cancer cell populations contain a small proportion of cells that display stem-like cell properties and which may be responsible for overall tumor maintenance. These cancer stem-like cells (CSCs) appear to have unique tumor-initiating ability and innate survival mechanisms that allow them to resist cancer therapies, consequently promoting relapses. Selective targeting of CSCs may provide therapeutic benefit and several recent reports have indicated this may be possible. In this article, we review drugs targeting CSCs, in selected epithelial cell-derived cancers.Keywords
Funding Information
- Medical Research Council (MRC) Grant (G0700763)
- Cancer Research UK (CR-UK) project Grants (A9275, A10247)
This publication has 94 references indexed in Scilit:
- Understanding and targeting cancer stem cells: therapeutic implications and challengesActa Pharmacologica Sinica, 2013
- Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cellsBioorganic & Medicinal Chemistry, 2012
- Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cellsScientific Reports, 2012
- Targeting colorectal cancer stem cells with inducible caspase-9Apoptosis, 2012
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistanceDrug Resistance Updates, 2010
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene, 2010
- Wnt Proteins Are Self-Renewal Factors for Mammary Stem Cells and Promote Their Long-Term Expansion in CultureCell Stem Cell, 2010
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating featuresProceedings of the National Academy of Sciences, 2009
- CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenograftsBritish Journal of Cancer, 2009
- Small molecule–mediated disruption of Wnt-dependent signaling in tissue regeneration and cancerNature Chemical Biology, 2009